147 related articles for article (PubMed ID: 25132703)
1. Comparison of different blood collection, sample matrix, and immunoassay methods in a prenatal screening setting.
Pennings JL; Siljee JE; Imholz S; Kuc S; de Vries A; Schielen PC; Rodenburg W
Dis Markers; 2014; 2014():509821. PubMed ID: 25132703
[TBL] [Abstract][Full Text] [Related]
2. Dried blood spot measurement of pregnancy-associated plasma protein A (PAPP-A) and free β-subunit of human chorionic gonadotropin (β-hCG) from a low-resource setting.
Browne JL; Schielen PC; Belmouden I; Pennings JL; Klipstein-Grobusch K
Prenat Diagn; 2015 Jun; 35(6):592-7. PubMed ID: 25688936
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a dried blood spot assay to measure prenatal screening markers pregnancy-associated plasma protein a and free β-subunit of human chorionic gonadotropin.
Cowans NJ; Suonpaa M; Kouru H; Wright D; Spencer K
Clin Chem; 2013 Jun; 59(6):968-75. PubMed ID: 23426428
[TBL] [Abstract][Full Text] [Related]
4. Impact of blood collection method on first-trimester dried blood free Beta hCG and PAPP-A.
Krantz DA; Carmichael JB
Ann Clin Biochem; 2013 Nov; 50(Pt 6):611-2. PubMed ID: 23921168
[TBL] [Abstract][Full Text] [Related]
5. The significance of maternal blood pregnancy-associated plasma protein A (PAPP-A) and free beta-subunit of human chorionic gonadotropin (β-hCG) levels for the risk assessment of fetal trisomy 18 during the first prenatal testing between 11 and 13+6 weeks of pregnancy.
Ziolkowska K; Tobola-Wrobel K; Dydowicz P; Zurawski S; Pietryga M; Wysocka E
Ginekol Pol; 2020; 91(12):748-754. PubMed ID: 33447994
[TBL] [Abstract][Full Text] [Related]
6. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
Spencer K
Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
[TBL] [Abstract][Full Text] [Related]
7. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012600. PubMed ID: 28295158
[TBL] [Abstract][Full Text] [Related]
8. First trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011975. PubMed ID: 26617074
[TBL] [Abstract][Full Text] [Related]
9. The stability of free-β human chorionic gonadotrophin and pregnancy-associated plasma protein-A in first trimester dried blood spots.
Cowans NJ; Stamatopoulou A; Liitti P; Suonpaa M; Spencer K
Prenat Diagn; 2011 Mar; 31(3):293-8. PubMed ID: 21294137
[TBL] [Abstract][Full Text] [Related]
10. Maternal serum hyperglycosylated human chorionic gonadotrophin (HhCG) in the first trimester of pregnancies affected by Down syndrome, using a sialic acid-specific lectin immunoassay.
Spencer K; Talbot JA; Abushoufa RA
Prenat Diagn; 2002 Aug; 22(8):656-62. PubMed ID: 12210572
[TBL] [Abstract][Full Text] [Related]
11. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
12. First-trimester screening for trisomies in pregnancies with vanishing twin.
Chaveeva P; Wright A; Syngelaki A; Konstantinidou L; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 Mar; 55(3):326-331. PubMed ID: 31710734
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness, the economic considerations of prenatal screening strategies for trisomy 21 in the Czech Republic.
Dhaifalah I; Májek O
Ceska Gynekol; 2012 Feb; 77(1):39-51. PubMed ID: 22536640
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of human chorionic gonadotropin (beta hCG) levels and sonographic assesement of fetal nuchal translucency (NT) in singleton pregnancies between 11 and 14 weeks of gestation--Polish multi-centre research].
Borowski D; Czuba B; Cnota W; Hincz P; Czekierdowski A; Gajewska J; Jaczyńska R; Ceran A; Włoch A; Wyrwas D; Wiełgoś M; Szymusik I; Szaflik K; Sodowski K
Ginekol Pol; 2007 May; 78(5):384-7. PubMed ID: 17867331
[TBL] [Abstract][Full Text] [Related]
16. Preanalytical stability of maternal serum markers hCGβ and PAPP-A.
Veyrat B; Tosetti F; Morin JF; Moineau MP; Piedimonte A; Clément P; Dreux S; Muller F
Ann Biol Clin (Paris); 2017 Apr; 75(2):158-166. PubMed ID: 28377328
[TBL] [Abstract][Full Text] [Related]
17. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies.
Ong CY; Lee CP; Leung KY; Lau E; Tang MH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):651-5. PubMed ID: 16946227
[TBL] [Abstract][Full Text] [Related]
18. First-trimester maternal dried blood Down syndrome screening marker levels in early pregnancy loss.
Krantz D; Hallahan T; Ishack S; Macri VJ; Macri JN
Prenat Diagn; 2006 Dec; 26(12):1137-41. PubMed ID: 17009346
[TBL] [Abstract][Full Text] [Related]
19. The clinical usefulness of biochemical (free β-hCg, PaPP-a) and ultrasound (nuchal translucency) parameters in prenatal screening of trisomy 21 in the first trimester of pregnancy.
Ziolkowska K; Dydowicz P; Sobkowski M; Tobola-Wrobel K; Wysocka E; Pietryga M
Ginekol Pol; 2019; 90(3):161-166. PubMed ID: 30950006
[TBL] [Abstract][Full Text] [Related]
20. Correlations between maternal hepatitis B virus carrier status and Down's syndrome prenatal screening indicators and their effects on the screening results.
Huang L; Chen Y; Ning W; Chen Y; Yu D
J Obstet Gynaecol; 2022 Oct; 42(7):2793-2798. PubMed ID: 36036240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
